Navigation Links
Perot Systems and Harvard Pilgrim Extend IT and Business Process Service Relationship
Date:4/8/2008

Thirteen-Year, $1 Billion Contract Extension to produce $150 million of

Administrative Cost Savings for Harvard Pilgrim Over the Life of the

Agreement

PLANO, Texas, April 8, 2008 /PRNewswire-FirstCall/ -- Perot Systems Corporation (NYSE: PER) and Harvard Pilgrim Health Care today announced that they have extended their IT and Business Process Services Relationship through 2021.

Under this new 13-year, $1 billion contract, Harvard Pilgrim will realize approximately $150 million of administrative cost savings over the life of the agreement through the consolidation and leveraging of technology, administrative functions and redesign of administrative operations. Perot Systems will operate and support Harvard Pilgrim's information technology infrastructure, business applications, and administrative business operations.

"We are committed to helping Harvard Pilgrim to continue building upon their distinguished record of success," said Peter Altabef, president and CEO for Perot Systems. "Their dedication to the consumers of Healthcare reinforces the reasons why they are our nation's top health plan. We are pleased to have this opportunity to work with Harvard Pilgrim on this important and mutually beneficial initiative."

For three years in a row, Harvard Pilgrim has been ranked as the #1 health care plan in America, according to a joint ranking by U.S. News & World Report and the National Committee for Quality Assurance (NCQA). In addition to this accolade, J.D. Power and Associates' 2007 National health Insurance Plan Satisfaction Study recognized Harvard Pilgrim with the "Highest Member Satisfaction with Commercial Health Plans in the Northeast."

"Over eight years ago, Ha
'/>"/>

SOURCE Perot Systems Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Perot Systems and ChinaSoft to Pursue Chinese Healthcare Opportunities
2. Perot Systems and Oakwood Healthcare Deliver Advanced Technology & Revenue Cycle Solutions to Physicians
3. Jewish Hospital & St. Marys Healthcare Select Perot Systems for Technology Services
4. Syndicoms Collaborative Web Platform Chosen to Facilitate Clinical Trials for Lumbar Disc Device from Aesculap Implant Systems
5. Resource Systems and Silverchair Learning Systems Launch CareTracker Online Training Module
6. Saratoga Hospital Purchases Three IDC DR Systems
7. Terumo Cardiovascular Systems Responds to Allegations of Patent Infringement
8. Escalon(R) Announces China Registration for Sonomed PacScan(R) and E/Z-Scan(R) Series of A-scan, Pachymeter and B-Scan Systems
9. Answers On Demand (AOD) and Vocollect Healthcare Systems Announce a First in the Industry Strategic Partnership
10. Medical Mutual of Ohio Acquires Premier Health Systems
11. Cato Research Ltd. and Advanced Targeting Systems, Inc. Partner to Develop SP-SAP for Chronic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...he health care reform details emerge, more entrepr...all groups and business insurance premiums. Now, t...bsites such as the Small Business Health Insurance... Minneapolis, Minn. (PRWEB) July 3, 2009 -- Th...the House, which has entrepreneurs worried about h...
(Date:7/2/2009)...ers to Support Principles to Govern Health Insurer...swire-USNewswire/ -- Nearly nine out of ten voters...e too much influence over how doctors care for the...ort the concept of a "Health Insurer Code of Condu...les for health insurance companies with respect to...
(Date:7/2/2009)...PRNewswire-USNewswire/ -- Acetaminophen is an ingr...tion medicines to help relieve pain and reduce fev... name, Tylenol and prescription brand names, Vicod... the FDA met on June 30, 2009 to address liver rel...e committee voted 20-17 to urge the FDA to put a b...
(Date:7/2/2009)...2 Dr Daniel Goldberg, a leading Ne...dy to measure the effectiveness of using 5% Betadi...on, worldwide, highly contagious and often severe ... term visual impairment due to corneal involvement...ited to register to participate in the Betadine fo...
Breaking Medicine News(10 mins):Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 2Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 3Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 2Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 3Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 4Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 5Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 6Health News:Viles & Beckman, LLC: Stop Your Headache NOT Your Liver 2Health News:Ophthalmologists Invited To Participate in Betadine for EKC Treatment Study 2
...s been appointed honorary consultant and adviser t...peciality of plastic, hand and reconstructive micr... Department of surgery in Ganga Medical Centre and...on and perform major operations to members of arme...
...cancer which has very poor prognosis. This is main...ad in the body//. The spread of cancer cells in th...be very fatal in case of cancer patients as it blo...s in early death. Hence early detection and treat...
...mes to their bowel cancer screening test? This is .../ of the first Australian national bowel cancer sc...ng the benefits and harms of alternate screening m...ded not to offer consumers a choice of screening t...
...ve smoking worsens allergies.The study, entitled “...ates// allergic airway disease in human beings” ca...urnal of Allergy and Clinical Immunology (JACI) We... the peer-reviewed journal of the American Academy...
Other Medicine News:Health News:IMP3 the Novel Biomarker for Metastatic Cancer 2Health News:IMP3 the Novel Biomarker for Metastatic Cancer 3Health News:Choosing your Bowel Cancer Test 2Health News:Passive Smoking Worsens Allergies 2
(Date:6/30/2009)..., MIDLOTHIAN, Va., June 30 In tw...LC Plus nebulizer and PRONEB compressors (Ultra an...terol fumarate (Perforomist, DEY LP, Mylan Inc.) i...d that researchers chose PARI products as the excl...ng maintenance treatments for COPD. Sutherland et...
(Date:6/30/2009)..., AMSTERDAM, The Netherlands, June 30 /PRNew...t on the Decision-Making Process With,Respect to ...conomic analysis presented today at this year,s,E...gy (ESHRE) congress showed,that, within the param...fertilisation (IVF) treatment MENOPUR (highly-puri...
(Date:6/29/2009)..., aTyr Pharma Targets for Novel Biotherapeutics ..., SAN DIEGO, June 29 Pangu BioPha...ay announced the filing of its third patent applic...d human tRNA synthetases. Although tRNA synthetas...in synthesis machinery found in all organisms, hum...
(Date:6/28/2009)..., CHIPPENHAM, England and TOKYO, June 29 /PR...tones for Both Companies , Sosei Group Corp...tura,Group plc ("Vectura"; LSE: VEC) announce the...vartis, with NVA237, a once-daily, long-acting mus...ronic obstructive pulmonary disease,(COPD). NVA23...
Breaking Medicine Technology:PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies 2New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF 2New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF 3New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF 4Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 2Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4Sangamo BioSciences and Sigma Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock Out Cell Lines 1579 1Sangamo BioSciences and Sigma Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock Out Cell Lines 1579 2Sangamo BioSciences and Sigma Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock Out Cell Lines 1579 3Sangamo BioSciences and Sigma Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock Out Cell Lines 1579 4Sangamo BioSciences and Sigma Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock Out Cell Lines 1579 5HeartWare Selects Allen 26 Caron for Investor Relations and Corporate Communications 14923 1HeartWare Selects Allen 26 Caron for Investor Relations and Corporate Communications 14923 2STMicroelectronics and Veredus Laboratories Launch Markets First Lab on Chip for Rapid Molecular Flu Detection at Point of Need 14920 1STMicroelectronics and Veredus Laboratories Launch Markets First Lab on Chip for Rapid Molecular Flu Detection at Point of Need 14920 2STMicroelectronics and Veredus Laboratories Launch Markets First Lab on Chip for Rapid Molecular Flu Detection at Point of Need 14920 3Therapeutic cloning treats Parkinsons disease in mice 14916 1
...I Intergroupe Francophone du Myelome (IFM),Trial P...2007 /PRNewswire-FirstCall/ --,Millennium Pharmace...esented on the comparative Phase III clinical tria...nosed multiple myeloma (MM),patients. As induction... the VELCADE based therapy produced a high complet...
...ine for Second Pivotal Phase 3 Trial CL-05, CHICAG...d Life,Sciences Holdings, Inc. , today announced t... Trial CL-06, the first of two,pivotal Phase 3 cli...ectiveness of cethromycin, a novel once-a-day anti...eumonia (CAP). The Company,also provided an update...
Other Medicine Technology:Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 2Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 3Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 4Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 5Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 2Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 3Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 4Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 5Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 7
PacePath is a comprehensive anatomic pathology software system that is the culmination of more than five years of development and testing by leading industry experts.
...ws NT client server system that combines unmatched...speed volume required to meet the most demanding l...Net is structured to make generating and distribut... Our system can upload lab activity to electronic ...
LabPak II is a comprehensive multi-user Laboratory Information System designed to meet the requirements of the larger POL, small hospital or private laboratory. It is the next step up from the LabPak
...tures a "U" fenestration with wide adhesive area. ...esion with no residue. Aggressive adhesive with no...are matte finish film and a split poly liner for e...tification. , ,Available sterile in a box of 10 or...
Medicine Products: